Apolipoprotein E allele ε4 (APOE*ε4), the best-established genetic risk factor for sporadic AD, can also influence the degree of microglial activation in response to Aβ deposition (Barger and Harmon, 1997; Rodriguez et al., 2014). This evidence concerns the gene APOE and Alzheimer disease.